Barclays’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-24,000
Closed -$1.77M – 5295
2024
Q1
$1.77M Buy
+24,000
New +$1.98M ﹤0.01% 2675

Other funds holding TMDX

Barclays's TMDX Position: Q3 2026 in Review

Barclays increased its Transmedics (TMDX) stake by 40% in Q3 2026, buying an estimated $7.81M and bringing the position to 332,599 shares worth $27.8M. The position accounts for 0.01% of the portfolio, ranked #1070.

Barclays first reported a position in TMDX in Q2 2019 and has held it in 30 quarters since. The position peaked at $30M in Q3 2024. 386 funds tracked by Wall St. Rank hold TMDX as of Q3 2026.

  • Barclays held 332,599 shares of Transmedics worth $27.8M as of Q3 2026.
  • Barclays bought 94,984 Transmedics shares in Q3 2026, an estimated $7.81M.
  • Transmedics made up 0.01% of Barclays's portfolio in Q3 2026, its #1070 holding.
  • Barclays first reported a position in Transmedics in Q2 2019 and has held it in 30 quarters since.
  • Barclays's Transmedics position peaked at $30M in Q3 2024.
  • 386 funds tracked by Wall St. Rank held Transmedics as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.